Products may contain dangerous ingredients such as prescription drugs that are not listed on the label, or the label may indicate a dangerous ingredient or combination of ingredients.
Various unauthorized health products promoted for sexual enhancement, weight loss, as a workout aid, as “poppers,” or for lightening skin or treating skin conditions (such as eczema or psoriasis).
Stop using these products and consult your healthcare professional if you have health concerns. Report these or any unauthorized health products to Health Canada.
Product description | Common name |
---|---|
Issue
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table below is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as “poppers,” or for lightening skin or treating skin conditions (such as eczema or psoriasis). These products are labelled to contain or have been tested and found to contain dangerous ingredients. Links to previous tables with affected products are also available below. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, effectiveness and quality. Unauthorized health products can pose many health dangers, including:
Health Canada maintains this page so that Canadians can easily identify products they may have purchased and take appropriate action. Canadians are encouraged to check back regularly for updates. Advisories on safety issues involving other types of products are available in the recalls and safety alerts database. What you should do
What companies should know:
BackgroundCardarine (also known as GW501516 and GW1516), MK-677 and SR-9009 are not authorized in Canada for any use and may pose serious health risks. All clinical development activities to bring GW501516 to market were stopped when toxicities, including various cancers, were discovered following routine, long-term animal studies. The long-term effects in humans are unknown. Selective Androgen Receptor Modulators (SARMs) are drugs that are not authorized in Canada for any use and have not been reviewed by Health Canada for safety, effectiveness and quality. The use of bodybuilding products that contain SARMs can pose serious health risks such as heart attack, stroke and liver damage. The long-term effects on the body are unknown. Examples include andarine, ostarine (MK 2866), ligandrol (LGD-4033) myostine (YK-11), and testolone (RAD-140). Sildenafil is a prescription drug used to treat erectile dysfunction and should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss. Desmethyl carbodenafil and dithiodesmethyl carbodenafil, and Hydroxythiohomosildenafil are unauthorized substances that are similar to sildenafil and may pose similar health risks. Tadalafil is a prescription drug used to treat erectile dysfunction and should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) since it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.Aminotadalafil is an unauthorized substance that is similar to tadalafil and may pose similar health risks. Related alertsUnauthorized products may pose serious health risks (November 17, 2017 to May 23, 2018) 2017-11-17 | Natural health products Type of communication: Advisory Unauthorized products may pose serious health risks (June 5, 2018 to November 7, 2018) 2018-06-05 | Natural health products Type of communication: Advisory Unauthorized products may pose serious health risks (December 10, 2018 to April 17, 2019) 2018-12-10 | Natural health products Type of communication: Advisory Unauthorized products may pose serious health risks (May 17, 2019 - Part 1) 2019-05-17 | Natural health products Type of communication: Advisory Unauthorized products may pose serious health risks (May 17, 2019 - Part 2) 2019-05-17 | Natural health products Type of communication: Advisory Unauthorized products may pose serious health risks (June 11, 2019 to July 26, 2019) 2019-06-11 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (August 12, 2019 to September 18, 2019) 2019-08-12 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (October 2, 2019 to November 19, 2019) 2019-10-02 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (December 9, 2019 to January, 17 2020) 2019-12-09 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (February 10, 2020 to March 13, 2020) 2020-02-10 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (September 16, 2020: Part 1) 2020-09-16 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (September 16, 2020: Part 2) 2020-09-16 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (October 21, 2020) 2020-10-21 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (November 25, 2020) 2020-11-25 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (Part 1) (February 18, 2021) 2021-02-18 | Drugs Type of communication: Advisory Unauthorized products may pose serious health risks (Part 2) (February 18, 2021) 2021-02-18 | Drugs Type of communication: Advisory For more informationMedia enquiriesPublic enquiries
|